Serotonin reuptake inhibitors augmentation with cariprazine in patients with treatment-resistant obsessive-compulsive disorder: a retrospective observational study

被引：0
|
作者：
Martiadis, Vassilis [1 ]
Pessina, Enrico [2 ]
Martini, Azzurra [2 ]
Raffone, Fabiola [1 ]
Cattaneo, Carlo I. [3 ]
De Berardis, Domenico [4 ]
Pampaloni, Ilenia [5 ]
机构：
[1] ASL Napoli 1 Ctr, Dept Mental Hlth, Naples, Italy
[2] ASL CN2, Dept Mental Hlth, Bra, Italy
[3] ASL 12, Dept Mental Hlth, Biella, Italy
[4] ASL 4 Teramo, Dept Mental Hlth, Teramo, Italy
[5] South West London & St Georges Mental Hlth NHS Tru, Natl OCD BDD Serv, London, England
来源：
CNS SPECTRUMS | 2024年
关键词：
OCD; augmentation strategies; cariprazine; antipsychotic augmentation; refractory OCD; ANTIPSYCHOTIC AUGMENTATION; DOUBLE-BLIND;
D O I：
10.1017/S1092852924000348
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] A REVIEW OF SEROTONIN REUPTAKE INHIBITORS IN OBSESSIVE-COMPULSIVE DISORDER
    KIM, SW
    DYSKEN, MW
    PSYCHIATRIC ANNALS, 1988, 18 (06) : 373 - +
  • [22] TREATING OBSESSIVE-COMPULSIVE DISORDER WITH SEROTONIN REUPTAKE INHIBITORS
    Brakoulias, V.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 68 - 68
  • [23] Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder
    Walsh, KH
    McDougle, CJ
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (10) : 2059 - 2067
  • [24] Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: A crossover study
    Li, XH
    May, RS
    Tolbert, LC
    Jackson, WT
    Flournoy, JM
    Baxter, LR
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (06) : 736 - 743
  • [25] Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary Study
    Bruno, Antonio
    Pandolfo, Gianluca
    Cedro, Clemente
    Gallo, Giuseppa
    De Felice, Mariangela
    Zoccali, Rocco A.
    Muscatello, Maria Rosaria A.
    CLINICAL NEUROPHARMACOLOGY, 2016, 39 (01) : 6 - 9
  • [26] Treatment-resistant obsessive-compulsive disorder
    Pallanti, S.
    Bernardi, S.
    Castellini, G.
    Quercioli, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S209 - S209
  • [27] Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: A six-month follow-up case series
    Dell'Osso, Bernardo
    Mundo, Emanuela
    Altamura, A. Carlo
    CNS SPECTRUMS, 2006, 11 (11) : 879 - 883
  • [28] Toxoplasmosis in Treatment-Resistant Obsessive-Compulsive Disorder Patients
    Kazemi, Forough
    Sayyah, Mehdi
    Tavalla, Mehdi
    Arjmand, Reza
    ACTA PARASITOLOGICA, 2022, 67 (01) : 356 - 361
  • [29] Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: is response to treatment predictable?
    Carey, Paul D.
    Lochner, Christine
    Kidd, Martin
    Van Ameringen, Michael
    Stein, Dan J.
    Denys, Damiaan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (06) : 321 - 325
  • [30] Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis
    Maiti, Rituparna
    Mishra, Archana
    Srinivasan, Anand
    Mishra, Biswa Ranjan
    ACTA PSYCHIATRICA SCANDINAVICA, 2023, 148 (01) : 19 - 31
12345